Europe Virology Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Virology Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Virology Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Virology Market Regional Analysis

6.2 Europe Virology Market Revenue 2019-2028 (US$ Million)

6.3 Europe Virology Market Forecast Analysis

7. Europe Virology Market Analysis – by Type

7.1 Diagnostic Test

7.1.1 Overview
7.1.2 Diagnostic Test: Europe Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Viral Infection Controlling Techniques

7.2.1 Overview
7.2.2 Viral Infection Controlling Techniques: Europe Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Antiviral Therapeutics

7.3.1 Overview
7.3.2 Antiviral Therapeutics: Europe Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.4 Interferons

7.4.1 Overview
7.4.2 Interferons: Europe Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe Virology Market Analysis – by Application

8.1 Skin and Soft Tissue Infections

8.1.1 Overview
8.1.2 Skin and Soft Tissue Infections: Europe Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Respiratory Tract Infections

8.2.1 Overview
8.2.2 Respiratory Tract Infections: Europe Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 GI Tract Infections

8.3.1 Overview
8.3.2 GI Tract Infections: Europe Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Sexually Transmitted Diseases

8.4.1 Overview
8.4.2 Sexually Transmitted Diseases: Europe Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.5 Urinary Tract Infection

8.5.1 Overview
8.5.2 Urinary Tract Infection: Europe Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe Virology Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: Europe Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Diagnostic Laboratories

9.2.1 Overview
9.2.2 Diagnostic Laboratories: Europe Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Pharmaceutical and Biotechnological Companies

9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnological Companies: Europe Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Research and Academic Institutes

9.4.1 Overview
9.4.2 Research and Academic Institutes : Europe Virology Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Europe Virology Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Virology Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 Europe Virology Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Virology Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 UK: Europe Virology Market Breakdown, by Type
10.2.1.1.2 UK: Europe Virology Market Breakdown, by Application
10.2.1.1.3 UK: Europe Virology Market Breakdown, by End User

10.2.1.2 Germany: Europe Virology Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Germany: Europe Virology Market Breakdown, by Type
10.2.1.2.2 Germany: Europe Virology Market Breakdown, by Application
10.2.1.2.3 Germany: Europe Virology Market Breakdown, by End User

10.2.1.3 France: Europe Virology Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 France: Europe Virology Market Breakdown, by Type
10.2.1.3.2 France: Europe Virology Market Breakdown, by Application
10.2.1.3.3 France: Europe Virology Market Breakdown, by End User

10.2.1.4 Russia: Europe Virology Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Russia: Europe Virology Market Breakdown, by Type
10.2.1.4.2 Russia: Europe Virology Market Breakdown, by Application
10.2.1.4.3 Russia: Europe Virology Market Breakdown, by End User

10.2.1.5 Italy: Europe Virology Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.5.1 Italy: Europe Virology Market Breakdown, by Type
10.2.1.5.2 Italy: Europe Virology Market Breakdown, by Application
10.2.1.5.3 Italy: Europe Virology Market Breakdown, by End User

10.2.1.6 Rest of Europe: Europe Virology Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Virology Market Breakdown, by Type
10.2.1.6.2 Rest of Europe: Europe Virology Market Breakdown, by Application
10.2.1.6.3 Rest of Europe: Europe Virology Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 AbbVie Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 F. Hoffmann-La Roche Ltd.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Gilead Sciences, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 GlaxoSmithKline Plc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Illumina, Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Johnson and Johnson Services, Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 QIAGEN

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Siemens AG

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Thermo Fisher Scientific Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Virology Market